Install
Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.
- 391articles · 365d
- 3+ day agolatest article
- Sep 15, 2025earliest in window
- 93%with images
- 262avg words
- Economy, Business & Finance 299
- Business & Industrial 250
- Medical 239
- Health & Wellness 137
- Finance & Business 80
- Health 60
- Transportation 33
- Industrial 28
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
How Pharma Will Navigate the NDC-12 Transition
1+ week, 18+ hour ago (28+ words) Pharmaceutical Commerce Liberty Dewey, DSCSA manager at Cardinal Health, breaks down the tools Pharma will use to navigate the NDC-12 transition....
Beyond the Patent Cliff: Why Generics and Biosimilars Demand Different Playbooks
1+ week, 5+ day ago (798+ words) The biopharmaceutical landscape is in the middle of its most dramatic structural reshuffling in decades. Fueled by record numbers of loss‑of‑exclusivity (LOE) events and pressure from payers to tame specialty‑drug inflation, the industry is watching two very…...
How Lilly's AtaiBeckley Deal Accelerates Psychedelic Drug Commercialization Push
1+ mon, 4+ week ago (212+ words) South San Francisco, CA, USA - Feb 23, 2024: Lilly logo is seen at the Eli Lilly Gateway Labs in South San Francisco, California. Eli Lilly and Company is an American pharmaceutical company. | © Tada Images (755396730) "Millions of people are still searching for relief…...
How Real-Time DTP Data Are Rewriting Pharma's Commercial Playbook
2+ mon, 1+ week ago (510+ words) Pharmaceutical Commerce...
How Patient Data from DTP Models Shape Commercial Decisions
2+ mon, 1+ week ago (11+ words) Pharmaceutical Commerce...
What's Driving Direct-to-Patient Model Adoption Across Pharma?
2+ mon, 1+ week ago (36+ words) Pharmaceutical Commerce Trending on Pharmaceutical Commerce The Hidden Architecture of Drug Shortages: Why Inventory Economics Determine Patient Access The RWE Communication Gap That's Costing Manufacturers Formulary Access...
From Promise to Proof: The Shakeup in Today’s Biosimilar Market
3+ mon, 3+ week ago (313+ words) Biosimilars were once framed mostly as a future cost-saving opportunity. Even so, availability on its own doesn’t lower spending. Savings depend on what happens after approval and after launch, when payer decisions, formulary positioning, prescribing habits, and operational follow-through begin…...
Megan Wetzel: What Will Shape Pharma?
3+ mon, 4+ week ago (52+ words) Pharmaceutical Commerce Trending on Pharmaceutical Commerce BIOSECURE and Beyond: What it Really Means for Pharma Supply Chains How MFN Impacts Drug Development and Launch Planning Pharma Pulse: The FDA Shake-Up and Growing Frustration with Prior Auth Reform How Pharma Can…...
Why 75 Top Pharma Execs Are Ditching Fragmented Marketing Stacks
3+ mon, 4+ week ago (441+ words) At the Doceree Makers Summit, leaders from Sanofi, Bristol Myers Squibb, Eli Lilly, and others backed a new pharma marketing operating model to replace fragmented legacy softwares. The announcement was made during the inaugural Doceree Health Decode: The Makers Summit…...